Brenda J Gehrke

5PUBLICATIONS
55CO-AUTHORS
Obstetrics and gynaecologyMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 27, 2025
FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy.

Robert Q Le, Kamar Godder, Jingyan Wang

|Oct 30, 2024
FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation.

Ashley C Woods, Kelly J Norsworthy, Moran Choe

|Oct 16, 2024
FDA Approval Summary: Teclistamab-A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple Myeloma.

Andrea C Baines, Bindu Kanapuru, Jay Zhao

|Aug 01, 2024
FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation.

Gulsum E Pamuk, Edwin C Y Chow, Alexei C Ionan

|Jul 05, 2024
Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding.

Jorge E Cortes, Elisabetta Abruzzese, Elyce H Cardonick

Pageof 1

Frequent Collaborators

5 joint publications

Marc R Theoret

4 joint publications

R Angelo De Claro

3 joint publications

Jonathon Vallejo

2 joint publications

Nan Zheng